QR-Code

Management of bleeding events and invasive procedures in patients with haemophilia A without inhibitors treated with emicizumab

INTRODUCTION Emicizumab (Hemlibra®, Hoffmann-La Roche, Switzerland) is now available for haemophilia A patients with or without factor VIII inhibitors. Management of bleeding events and replacement therapy for invasive procedures have to be adapted. OBJECTIVE...

Ausführliche Beschreibung

Gespeichert in:
Hauptverfasser: Pierre Fontana, Lorenzo Alberio, Manuela Albisetti, Anne Angelillo-Scherrer, Lars M. Asmis, Alessandro Casini, Bernhard Gerber, Lukas Graf, Inga Hegemann, Wolfgang Korte, Maria Martinez, Jan-Dirk Studt, Dimitrios A. Tsakiris, Walter A. Wuillemin, Johanna A. Kremer Hovinga
Format: Artigo
Sprache:Inglês
Veröffentlicht: SMW supporting association (Trägerverein Swiss Medical Weekly SMW) 2020-12-01
Schriftenreihe:Swiss Medical Weekly
Schlagworte:
emicizumab
bleeds
invasive procedures
Guidelines
Online-Zugang:https://www.smw.ch/index.php/smw/article/view/2933
Tags: Tag hinzufügen
Keine Tags, Fügen Sie das erste Tag hinzu!

Ähnliche Einträge